Table 1. Areas of indication and types of application of digital health applications (DiGA) (excerpt: Indication Depression, eTable 1).
| Deprexis | Selfapy’s online course for depression |
Novego:
Coping with depression |
Edupression.com | Elona therapy Depression |
| Type of application | ||||
| Web application*1 | Web application*1 + Smartphone app*2 |
Web application*1 | Web application*1 | Web application*1 + Smartphone app*2 |
| Listing status | ||||
| Final | Final | 10.10.2021–09.10.2022*3 | 26.12.2022–25.08.2022*3 | 26.12.2022–25.12.2023*3 |
| Indications | ||||
| ● Mild to severe depressive episode (F32.0, F32.1, F32.2) ● Recurrent depressive disorder (F33.0, F33.1, F33.2) |
● Mild and moderate depressive episode (F32.0, F32.1) ● Recurrent depressive disorder (F33.0, F33.1) |
● Mild and moderate depressive episode (F32.0, F32.1) ● Recurrent depressive disorder (F33.0, F33.1) ● Dysthymia (F34.1) |
● Mild and moderate depressive episode (F32.0, F32.1) ● Recurrent depressive disorder (F33.0, F33.1) |
● Mild and moderate depressive episode (F32.0, F32.1) ● Recurrent depressive disorder (F33.0, F33.1) ● Dysthymia (F34.1) |
| Contraindications | ||||
| ● Schizophrenia (F20) ● Acute transient psychotic disorder (F23) ● Schizoaffective disorders (F25) ● Bipolar disorder (F31) ● Other symptoms and signs involving emotional state (R45.8) ● Suicidal risk |
● Alzheimer dementia (F00) ● Alcohol dependence and withdrawal syndrome (F10.2, F10.3) ● Schizophrenia (F20) ● Bipolar disorder (F31) ● Severe depressive episode with psychotic symptoms (F32.3, F33.3) ● Acute suicidality |
● Organic mental disorder (F0x) ● Dependence disorder (F1x.2) ● Psychotic disorder (F2x) ● Bipolar disorder (F31) ● Mania (F30.0) ● Suicidality in the last 4 weeks |
● Schizotypal disorder (F21) ● Persistent delusional disorders(F22) ● Bipolar disorder (F31) ● Severe depressive episode with psychotic symptoms (F32.3, F33.3) ● Suicidality ● Psychotic disorder (F2x) |
● Psychotic disorder (F2x) ● Bipolar disorder (F31) ● Mania (F30) ● Severe depressive episode with psychotic symptoms (F32.3, F33.3) ● Acute suicidality |
| Duration of use | ||||
| At least 90 days (1–2 x/week minimum duration 30 min each) |
At least 90 days | At least 90 days | At least 90 days | At least 90 days |
| Costs/quarter (€) | ||||
| 210.00 | 217.18 | 249.00 | 357.00 (follow-up prescription: 178.50) |
535.49 |
| Foreign languages | ||||
| ELL, ENG, FRA, ITA, POR, SPA, SWE, ZHO | – | – | ENG | – |
*1 Web application (internet-enabled end device)
*2 Smartphone app (Android/ iOS smartphone)
*3 In case of provisional listing in the BfArM‘s DiGA Directory, the trial period is stated.
ELL, Greek; ENG, English; FRA, French; ITA, Italian; POR, Portuguese; SPA, Spanish; SWE, Swedish; ZHO, Chinese